TH20954Y - An eye care product formulated with catechin extract. - Google Patents

Abstract

------13/05/2019------(OCR) Page 1 of 1 page Summary of the invention: A formula for an eye care product made from catechin extract, consisting of two parts: (1) Oil Phase, which includes triethylhexanoine (Triethylhexanoin), Cetyl Alcohol, Tocopheryl Acetate, Sorbitan Stearate, Ceteareth-20, Ascorbyl tetraisopalmitate, Phenyl Trimethicone, Tocopherol and (2) Aqueous Phase: Aqua, Cyclopentasiloxane and Dimethicone Crosspolymer and Dimethicone and Laureth-23 and Laureth-4, bio extract Complex B. B), Panthenol, Niacinamide, Butylene Glycol, Glycerin, PEG-40 Hydrogenated Castor Oil, Phenoxyethanol, Sodium hyaluronate, Disodium EDTA, Dipotassium Glycyrrhizate and Catechin ------------ ------13/05/2019------(OCR) Page 1 of 1 page Summary of the invention The eye care product formulation is made from catechin extract and consists of 2 parts: (1) Oil Phase, which includes Triethylhexanoene (Triethylhexanoin), Cetyl Alcohol, Tocopheryl Acetate, Sorbitan Stearate, Ceteareth-20, Ascorbyl tetraisopalmitate, Phenyl Trimethicone, Tocopherol and (2) Aqueous Phase: Aqua, Cyclopentasiloxane and Dimethicone Crosspolymer and Dimethicone and Laureth-23 and Laureth-4, bio extract Complex B. B), Panthenol, Niacinamide, Butylene Glycol, Glycerin, PEG-40 Hydrogenated Castor Oil, Phenoxyethanol, Sodium hyaluronate, Disodium EDTA, Dipotassium Glycyrrhizate and Catechin ------------ ------13/05/2019------(OCR) Page 1 of 1 page Summary of the invention The eye care product formulation is made from catechin extract and consists of 2 parts: (1) Oil Phase, which includes Triethylhexanoene (Triethylhexanoin), Cetyl Alcohol, Tocopheryl Acetate, Sorbitan Stearate, Ceteareth-20, Ascorbyl tetraisopalmitate, Phenyl Trimethicone, Tocopherol and (2) Aqueous Phase: Aqua, Cyclopentasiloxane and Dimethicone Crosspolymer and Dimethicone and Laureth-23 and Laureth-4, bio extract Complex B. B), Panthenol, Niacinamide, Butylene Glycol, Glycerin, PEG-40 Hydrogenated Castor Oil, Phenoxyethanol, Sodium Hyaluronate, Disodium EDTA, Dipotassium Glycyrrhizate and Catechin. ------------ Page 1 of 1. Abstract of the Invention: An eye cream formulation derived from catechin extracts as per claims 1 and 2, containing catechin extract from tea leaves with antioxidant and tyrosinase inhibitory activity. which is the cause of the formation of dark spots on the skin and the enzyme matrix metalloproteinase-1 (MMP-1) or collagen (collagenases-1) is an enzyme that breaks down collagen in the skin causing the skin to have wrinkles. It has 2 components: (1) Oil Phase, which includes triethylhexanoine (Triethylhexanoin), Cetyl Alcohol, Tocopheryl Acetate, Sorbitan Stearate, Ceteareth-20, Ascorbyl tetraisopalmitate, Phenyl Trimethicone, Tocopherol and (2) Aqueous Phase: Aqua, Cyclopentasiloxane (and) Dimethicone Crosspolymer (and) Dimethicone (and) Laureth-23 (and) Laureth-4), bio extract Complex B, Panthenol, Niacinamide, Butylene Glycol, Glycerin, PEG-40 Hydrogenated Castor Oil, Phenoxyethanol, Sodium Hyaluronate, Disodium EDTA, Dipotassium Glycyrrhizate, and Catechin.

Claims (3)

------13/05/2562------(OCR) Page 1 of 1 page. Claim 1. The eye care product formula from catechin extract contains the following components: Oil Phase: Triethylhexanorene Triethylhexanoin 5.00-6.00% by weight, Cetyl Alcohol 4.50-5.50% by weight, Tocopheryl Acetate 3.50-4.50% by weight, Sorbitan Stearate 2.50-3.00% by weight, Ceteareth-20 2.00-2.50% by weight, Ascorbyl tetraisopalmitate 1.60-2.25% by weight, Phenyl Trimethicone 1.60-2.25% by weight, Tocopherol 0.40-0.65% by weight (Water phase) (Aqueous Phase) Water (Aqua) 9.00-10.00% by weight, Cyclopentasiloxane and Dimethicone Crosspolymer and Dimethicone 11.50-12.50% by weight, and Laureth-23 and Laureth-4, Bio Extract Complex B 1.50-2.50% by weight, Panthenol 3.50-4.50% by weight, Niacinamide 1.50-2.50% by weight, Butylene Glycol 0.50-1.50% by weight, Glycerin. 0.50-1.50% by weight PEG-40 Hydrogenated Castor Oil, 0.50-0.80% by weight Phenoxyethanol, 0.35-0.50% by weight Sodium hyaluronate, 38.00-42.00% by weight Disodium EDTA, 1.50-2.50% by weight Dipotassium Glycyrrhizate, 0.02-0.08% by weight Catechin, 0.50-1.20% by weight. The eye care product formulation from catechin extract under patent claim 1 contains the following ingredients: Oil Phase: Triethylhexanorene Triethylhexanoin 5.00-6.00% by weight, Cetyl Alcohol 4.50-5.50% by weight, Tocopheryl Acetate 3.50-4.50% by weight, Sorbitan Stearate 2.50-3.00% by weight, Ceteareth-20 2.00-2.50% by weight, Ascorbyl tetraisopalmitate 1.60-2.25% by weight, Phenyl Trimethicone 1.60-2.25% by weight, Tocopherol 0.40-0.65% by weight (Water phase) (Aqueous Phase) Water (Aqua) 9.00-10.00% by weight, Cyclopentasiloxane and Dimethicone Crosspolymer and Dimethicone 11.50-12.50% by weight, and Laureth-23 and Laureth-4, Bio Extract Complex B 1.50-2.50% by weight, Panthenol 3.50-4.50% by weight, Niacinamide 1.50-2.50% by weight, Butylene Glycol 0.50-1.50% by weight, Glycerin. 0.50-1.50% by weight PEG-40 Hydrogenated Castor Oil, 0.50-0.80% by weight Phenoxyethanol, 0.35-0.50% by weight Sodium hyaluronate, 38.00-42.00% by weight Disodium EDTA, 1.50-2.50% by weight Dipotassium Glycyrrhizate, 0.02-0.08% by weight Catechin, 0.50-1.20% by weight. The eye care product formulation from catechin extract under patent claim 1 contains the following ingredients: Oil Phase: Triethylhexanorene Triethylhexanoin 5.00-6.00% by weight, Cetyl Alcohol 4.50-5.50% by weight, Tocopheryl Acetate 3.50-4.50% by weight, Sorbitan Stearate 2.50-3.00% by weight, Ceteareth-20 2.00-2.50% by weight, Ascorbyl tetraisopalmitate 1.60-2.25% by weight, Phenyl Trimethicone 1.60-2.25% by weight, Tocopherol 0.40-0.65% by weight (Water phase) (Aqueous Phase) Water (Aqua) 9.00-10.00% by weight, Cyclopentasiloxane and Dimethicone Crosspolymer and Dimethicone 11.50-12.50% by weight, and Laureth-23 and Laureth-4, Bio Extract Complex B 1.50-2.50% by weight, Panthenol 3.50-4.50% by weight, Niacinamide 1.50-2.50% by weight, Butylene Glycol 0.50-1.50% by weight, Glycerin. 0.50-1.50% by weight PEG-40 Hydrogenated Castor Oil, 0.50-0.80% by weight Phenoxyethanol, 0.35-0.50% by weight Sodium hyaluronate, 38.00-42.00% by weight Disodium EDTA, 1.50-2.50% by weight Dipotassium Glycyrrhizate, 0.02-0.08% by weight Catechin, 0.50-1.20% by weight. The formula for an eye cream product derived from catechin extract as per patent 1, which includes tea tree extract ------------ Page 1 of 2. Patent. 1. The eye care product formula, derived from catechin extract, contains the following components: Oil Phase: Triethylhexanoen Triethylhexanoin 5.00 - 6.00% by weight, Cetyl Alcohol 4.50 - 5.50% by weight, Tocopheryl Acetate 3.50 - 4.50% by weight, Sorbitan Stearate 2.50 - 3.00% by weight, Ceteareth-20 2.00 - 2.50% by weight, Ascorbyl tetraisopalmitate 1.60 - 2.25% by weight, Phenyl Trimethicone 1.60 - 2.25% by weight, Tocopherol 0.40 - 0.65%. The aqueous phase consists of: Water (Aqua) 9.00 - 10.00% by weight, Cyclopentasiloxane and Dimethicone Crosspolymer and Dimethicone (and) Laureth-23 and Laureth-4 (Bio Extract Complex B) 1.50 - 2.50% by weight, Panthenol 3.50 - 4.50% by weight, Niacinamide 1.50 - 2.50% by weight, and Butylene Glycol 0.50 - 1.50% by weight. Glycerin 0.50 - 1.50% by weight, PEG-40 Hydrogenated Castor Oil 0.50 - 0.80% by weight, Phenoxyethanol 0.35 - 0.50% by weight, Sodium hyaluronate 38.00 - 42.00% by weight, Disodium EDTA 1.50 - 2.50% by weight, Dipotassium Glycyrrhizate 0.02 - 0.08% by weight, Catechin 0.50 - 1.20% by weight. Total 100%. 2. The formulation of an eye care product from catechin extract, as per patent 1, contains key ingredients derived from catechin extract in tea leaves, which exhibits antioxidant properties and inhibits tyrosinase enzyme activity, a major cause of dark spots on the skin. It also inhibits matrix metalloproteinase-1 (MMP-1) or collagenases-1, an enzyme that breaks down collagen in the skin, leading to wrinkles. The product possesses properties that restore and delay the formation of wrinkles on the face, while brightening and smoothing dull and uneven skin tone. 3. A facial serum product formulation containing catechin extract, as per patents 1 and 2, in serum form or other forms.